Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Implementering, evaluering og opskalering af programmet Styrkelse af en palliativ tilgang i langtidspleje (SPA-LTC)

5. oktober 2026 opdateret af: McMaster University

This study will evaluate the implementation of the Strengthening a Palliative Approach in Long-Term Care (SPA-LTC) program using a cross-jurisdictional, effectiveness-implementation type II hybrid design (dual testing of clinical and implementation interventions) to assess the implementation (feasibility, fidelity, reach, sustainability) and effectiveness (family satisfaction, staff knowledge and confidence implementing a palliative approach to care, hospital use).

Studieoversigt

Status

Aktiv, ikke rekrutterende

Detaljeret beskrivelse

The SPA-LTC program has been developed and refined through prior participatory action based studies.

Evidence-based components of the program include:

Palliative Champion Teams; Palliative Care Education, including illness-trajectory pamphlets for staff and family members; Comfort Care Rounds with staff; Prognostic Tools to trigger end-of-life discussions; Palliative Care Conferences; Bereavement Pamphlets for families; and Post-Bereavement Follow-Up for families, and staff

The goal is to implement and assess this program across three provinces in Canada (Ontario, Saskatchewan, Manitoba). The investigators will use the findings to revise the program and inform the scaling up of the program across diverse settings and provinces.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

594

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Manitoba
      • Winnipeg, Manitoba, Canada
        • University of Manitoba
    • Ontario
      • Hamilton, Ontario, Canada
        • McMaster University
    • Saskatchewan
      • Regina, Saskatchewan, Canada
        • University of Regina
      • Saskatoon, Saskatchewan, Canada
        • University of Saskatchewan

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Barn
  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • English-speaking LTC residents with a score of 50% or less on the Palliative Performance Scale.

Exclusion Criteria:

  • Non-English speaking LTC residents
  • residents with a score of more than 50% on the Palliative Performance Scale.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Sundhedstjenesteforskning
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Intervention

Within the intervention arm 9 long-term care homes will receive the SPA-LTC program:3 in Ontario; 3 in Saskatchewan and 3 in Manitoba.

Our team will work with long-term care homes in the study to implement the Strengthening a Palliative Approach in Long Term Care (SPA-LTC) which consists of the following core, evidence-informed components:

Palliative Champion Teams (to provide leadership and support implementation); Palliative Care Education (including illness trajectory pamphlets); Comfort Care Rounds with staff (for capacity building and reflection); Prognostic Tools to trigger end-of-life discussions; Palliative Care Conferences with families and residents; Bereavement Pamphlets; and Post-Bereavement Follow-Up for families, and staff.

Ingen indgriben: Control

Within the control arm 9 long-term care homes will receive the standard of care: 3 in Ontario; 3 in Saskatchewan and 3 in Manitoba.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Tidsramme
Antal akutmodtagelsesbesøg i beboerens sidste leveår
Tidsramme: Alle beboere i hjemmet, der døde et år før implementeringen og et år før dødsdatoen for alle beboere i hjemmet, der dør i undersøgelsens interventionsperiode.
Alle beboere i hjemmet, der døde et år før implementeringen og et år før dødsdatoen for alle beboere i hjemmet, der dør i undersøgelsens interventionsperiode.

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Family Perceptions of End of Life Care
Tidsramme: Survey completed at enrolment into the study; survey completed 2 months after the Family Care Conference or 1 month after the end of the intervention period if no Family Care Conference occurred.

Survey

Survey completed at enrolment into the study; survey completed 2 months after the Family Care Conference or 1 month after the end of the intervention period if no Family Care Conference occurred.
Family Experiences with End of Life Care
Tidsramme: Interview completed at enrolment into the study; survey completed 2 months after the Family Care Conference or 1 month after the end of the intervention period if no Family Care Conference occurred.

Interview

Interview completed at enrolment into the study; survey completed 2 months after the Family Care Conference or 1 month after the end of the intervention period if no Family Care Conference occurred.
Staff Knowledge about a Palliative Approach to Care
Tidsramme: All staff in all participating long-term care homes will complete a staff survey at 2 points in the study: at the beginning and the end of the intervention

Survey

All staff in all participating long-term care homes will complete a staff survey at 2 points in the study: at the beginning and the end of the intervention
Number of Hospital Transfers per Resident
Tidsramme: Chart audit at start of the trial to capture data on residents who died in the year prior to the trial. Chart audits also during the transition phase prior to Steps 2 and 3; and one month after the intervention period for the trial ends.

Chart data at each study site will be audited to capture data on the number of hospital transfers in the last year of life for residents who died 1 year before the trial or who die during the trial.

Chart audit at start of the trial to capture data on residents who died in the year prior to the trial. Chart audits also during the transition phase prior to Steps 2 and 3; and one month after the intervention period for the trial ends.
Number of Hospital Deaths during the trial
Tidsramme: Chart audit at start of the trial to capture data on residents who died in the year prior to the trial. Chart audits also during the transition phase prior to Steps 2 and 3; and one month after the intervention period for the trial ends.

Chart data at each study site will be audited to capture data on the number of hospital deaths in the year prior to the trial and during the trial.

Chart data at each study site will be audited to capture data on the number of hospital transfers in the residents last year of life.

Chart audit at start of the trial to capture data on residents who died in the year prior to the trial. Chart audits also during the transition phase prior to Steps 2 and 3; and one month after the intervention period for the trial ends.
Bereaved Family Satisfaction with End of Life Care
Tidsramme: 6 weeks to 2 months after the resident's death

Qualitative interview with family members whose loved one died during the trial.

6 weeks to 2 months after the resident's death
Resident Satisfaction with End of Life Care
Tidsramme: At the time of enrolment and 2 months after the Family Care Conference or 1 month after the intervention period if no Family Care Conference occurred.

Qualitative interview with residents who are enrolled in the trial

At the time of enrolment and 2 months after the Family Care Conference or 1 month after the intervention period if no Family Care Conference occurred.

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Fidelity of the Intervention
Tidsramme: Checklist completed weekly during the intervention period for up to 160 weeks.

Checklist

Checklist completed weekly during the intervention period for up to 160 weeks.

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. juni 2022

Primær færdiggørelse (Faktiske)

31. januar 2025

Studieafslutning (Anslået)

31. januar 2028

Datoer for studieregistrering

Først indsendt

26. april 2019

Først indsendt, der opfyldte QC-kriterier

1. maj 2019

Først opslået (Faktiske)

2. maj 2019

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

6. oktober 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

5. oktober 2026

Sidst verificeret

1. oktober 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

There is no plan to make individual participant data (IPD) available to other researchers.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner